Mira Pharmaceuticals Inc (MIRA)
0.655
-0.02
(-3.61%)
USD |
NASDAQ |
May 17, 16:00
0.655
0.00 (0.00%)
After-Hours: 20:00
Mira Pharmaceuticals Market Cap: 9.682M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 9.682M |
| May 16, 2024 | 10.04M |
| May 15, 2024 | 10.41M |
| May 14, 2024 | 10.91M |
| May 13, 2024 | 10.60M |
| May 10, 2024 | 10.64M |
| May 09, 2024 | 11.09M |
| May 08, 2024 | 11.23M |
| May 07, 2024 | 11.23M |
| May 06, 2024 | 11.09M |
| May 03, 2024 | 10.83M |
| May 02, 2024 | 11.94M |
| May 01, 2024 | 12.11M |
| April 30, 2024 | 12.56M |
| April 29, 2024 | 12.56M |
| April 26, 2024 | 12.71M |
| April 25, 2024 | 13.30M |
| April 24, 2024 | 12.86M |
| April 23, 2024 | 12.98M |
| April 22, 2024 | 12.64M |
| April 19, 2024 | 12.29M |
| April 18, 2024 | 12.39M |
| April 17, 2024 | 11.97M |
| April 16, 2024 | 11.68M |
| April 15, 2024 | 12.27M |
| Date | Value |
|---|---|
| April 12, 2024 | 13.31M |
| April 11, 2024 | 14.49M |
| April 10, 2024 | 14.77M |
| April 09, 2024 | 14.78M |
| April 08, 2024 | 15.22M |
| April 05, 2024 | 15.08M |
| April 04, 2024 | 15.08M |
| April 03, 2024 | 15.82M |
| April 02, 2024 | 15.82M |
| April 01, 2024 | 15.96M |
| March 28, 2024 | 16.26M |
| March 27, 2024 | 16.11M |
| March 26, 2024 | 17.00M |
| March 25, 2024 | 17.15M |
| March 22, 2024 | 18.18M |
| March 21, 2024 | 18.62M |
| March 20, 2024 | 18.33M |
| March 19, 2024 | 17.59M |
| March 18, 2024 | 17.44M |
| March 15, 2024 | 17.44M |
| March 14, 2024 | 18.18M |
| March 13, 2024 | 16.26M |
| March 12, 2024 | 22.91M |
| March 11, 2024 | 22.17M |
| March 08, 2024 | 23.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.682M
Minimum
May 17 2024
109.41M
Maximum
Aug 03 2023
36.21M
Average
18.48M
Median
Market Cap Benchmarks
| Altimmune Inc | 567.93M |
| 180 Life Sciences Corp | 1.347M |
| NovaBay Pharmaceuticals Inc | 4.487M |
| Palatin Technologies Inc | 32.27M |
| iBio Inc | 6.899M |
Market Cap Related Metrics
| Price to Book Value | 2.213 |
| Price | 0.655 |
| Earnings Yield | -126.5% |